NPL Gene (N-Acetylneuraminate Pyruvate Lyase)
Gene encoding N-acetylneuraminate pyruvate lyase, involved in sialic acid catabolism
Gene Information Card
| Symbol | NPL |
|---|---|
| Full Name | N-acetylneuraminate pyruvate lyase |
| Gene Type | protein-coding |
| Chromosomal Location | 1q25.3 |
| NCBI Gene ID | 80896 ncbi.nlm.nih.gov/gene/80896 |
| Ensembl ID | ENSG00000135838 |
| UniProt ID | Q9BXD5 |
| OMIM ID | 608679 |
| HGNC ID | 16669 |
| Aliases | NPL1, NAL, N-acetylneuraminate lyase, sialate lyase |
Description
The NPL gene encodes N-acetylneuraminate pyruvate lyase, an enzyme that catalyzes the reversible cleavage of N-acetylneuraminate (sialic acid) to N-acetylmannosamine and pyruvate. This enzyme is a key regulator of sialic acid catabolism and is involved in the degradation of free sialic acid. Mutations in NPL are associated with sialuria and other disorders of sialic acid metabolism.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Sialuria (OMIM 269921) | Loss-of-function mutations in NPL impair sialic acid degradation, leading to accumulation of free sialic acid in urine and tissues. | ClinVar, OMIM |
| NPL deficiency | Homozygous or compound heterozygous mutations cause reduced enzyme activity, resulting in elevated urinary sialic acid. | ClinVar, OMIM |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Liver | 12.5 | Medium |
| Kidney | 8.3 | Medium |
| Brain | 6.1 | Low |
| Lung | 4.7 | Low |
| Spleen | 3.2 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| HepG2 | 10.1 | Hepatocellular carcinoma cell line |
| HEK293 | 7.8 | Embryonic kidney cells |
| A549 | 5.4 | Lung carcinoma cells |
| K562 | 2.9 | Leukemia cells |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1A>G (p.Met1?) | Missense | Rare | Loss of start codon, likely loss of function |
| c.214C>T (p.Arg72Trp) | Missense | <0.01% | Reduced enzyme activity |
| c.487G>A (p.Gly163Arg) | Missense | <0.01% | Impaired catalytic function |
| c.632delC (p.Pro211Leufs*2) | Frameshift | Rare | Premature truncation, loss of function |
Mutation functional classification
Loss of Function (LOF)
Most NPL mutations are loss-of-function, leading to reduced or absent enzyme activity and sialic acid accumulation.
Gain of Function (GOF)
No gain-of-function mutations reported.
Dominant Negative (DN)
No dominant-negative mutations reported.
View complete mutation data:
Gene Ontology (GO)
| • N-acetylneuraminate lyase activity | • pyruvate lyase activity |
| • sialic acid catabolic process | • carbohydrate metabolic process |
| • cytosol |
Pathways
• Amino sugar and nucleotide sugar metabolism (KEGG: hsa00520)
• Sialic acid metabolism (Reactome: R-HSA-4085001)
Protein Summary
N-acetylneuraminate pyruvate lyase is a homotetrameric enzyme localized to the cytosol. It catalyzes the cleavage of N-acetylneuraminate into N-acetylmannosamine and pyruvate, a critical step in sialic acid degradation. The enzyme is highly expressed in liver and kidney, consistent with its role in metabolic clearance. Structural studies show a (beta/alpha)8 barrel fold typical of class I aldolases.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| NPL Knockout HCT 116 Cell Line | EDJ-KQ74290 | Human | 80896 | Details Get a Quote |
| NPL Knockout A-549 Cell Line | EDJ-KQ65864 | Human | 80896 | Details Get a Quote |
| NPL Knockout HeLa Cell Line | EDJ-KQ36430 | Human | 80896 | Details Get a Quote |
| NPL Knockout HEK293 Cell Line | EDJ-KQ9596 | Human | 80896 | Details Get a Quote |